Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently the most common chronic liver disease worldwide. Its development is multifactorial and involves genetic predisposition, metabolic dysfunction, lifestyle, environmental influences, and the gut microbiome (25).
Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) is one of the most common and increasing liver diseases worldwide, with a prevalence of 20–33%. NAFLD may progress to fibrosis, compensated [cirrhosis](brain…